Aprepitant 40mg Capsules
Overview
What is this medicine?
How to Use This Medicine
To store this medication, keep it at room temperature in a dry place, avoiding the bathroom. If you miss a dose, contact your doctor for advice on what to do next.
Lifestyle & Tips
- Take the capsule whole with or without food, as directed by your doctor, usually within 3 hours before your surgery.
- Do not crush, chew, or open the capsule.
- Report any persistent nausea, vomiting, or unusual side effects to your healthcare provider.
- If you are taking warfarin, you will need extra blood tests (INR) to monitor your blood clotting.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of a severe skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis), including:
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Red or irritated eyes
+ Sores in the mouth, throat, nose, or eyes
Signs of dehydration, such as:
+ Dry skin, mouth, or eyes
+ Thirst
+ Fast heartbeat
+ Dizziness
+ Fast breathing
+ Confusion
Signs of infection, including:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or changed sputum production
+ Pain while urinating
+ Mouth sores
+ Wounds that will not heal
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical help if they bother you or do not go away:
Feeling dizzy, tired, or weak
Diarrhea or constipation
Decreased appetite
Stomach pain or heartburn
Hiccups
Headache
* Burping
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe dizziness or fainting
- Unusual bleeding or bruising (if on warfarin)
- Signs of an allergic reaction (e.g., rash, itching, swelling, severe dizziness, trouble breathing)
- Persistent or worsening nausea/vomiting despite medication
Before Using This Medicine
Any allergies you have, including allergies to this drug, any of its components, or other substances, such as foods or medications. Be sure to describe the symptoms you experienced as a result of the allergy.
Any medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins, as some of these may interact with this medication. Specifically, certain medications used to treat HIV, infections, seizures, and other conditions should not be taken with this drug.
* It is crucial to note that this is not an exhaustive list of all potential drug interactions or health problems that may affect the safety of taking this medication.
To ensure your safety, it is vital to provide your doctor and pharmacist with a comprehensive list of all your medications (prescription and OTC), natural products, vitamins, and health problems. This will enable them to assess whether it is safe for you to take this medication in conjunction with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
To avoid potential interactions, do not consume grapefruit or grapefruit juice while taking this drug.
If you are using birth control pills or other hormone-based birth control methods, be aware that this medication may reduce their effectiveness in preventing pregnancy. As a precaution, use an additional form of birth control, such as a condom, during treatment and for 1 month after the last dose.
If you are pregnant, planning to become pregnant, or are breast-feeding, consult your doctor to discuss the potential benefits and risks of this medication to both you and your baby.
Overdose Information
Overdose Symptoms:
- Limited experience with overdose. Symptoms may include drowsiness, headache, and fatigue.
What to Do:
There is no specific antidote for aprepitant overdose. In case of suspected overdose, discontinue the drug and provide supportive care. Due to high protein binding, hemodialysis is unlikely to be effective. Call 1-800-222-1222 (Poison Control Center) for further guidance.
Drug Interactions
Contraindicated Interactions
- Pimozide
- Terfenadine
- Astemizole
- Cisapride
Major Interactions
- Warfarin (INR monitoring required)
- Oral Contraceptives (reduced efficacy)
- Corticosteroids (e.g., Dexamethasone, Methylprednisolone - dose reduction needed)
- Midazolam (oral)
- Fentanyl
- Alfentanil
- Ergot alkaloids (e.g., Ergotamine, Dihydroergotamine)
- Immunosuppressants (e.g., Cyclosporine, Tacrolimus, Sirolimus, Everolimus)
- CYP3A4 substrates with narrow therapeutic index (e.g., Quinidine, Irinotecan, Vinca alkaloids)
Moderate Interactions
- Calcium channel blockers (e.g., Diltiazem, Verapamil)
- Statins (e.g., Simvastatin, Lovastatin)
- Phenytoin
- Carbamazepine
- Rifampin
- Phenobarbital
- St. John's Wort
- Paroxetine
Minor Interactions
- Not specifically identified as minor, but caution with any CYP3A4 substrate/inducer.
Monitoring
Baseline Monitoring
Rationale: Aprepitant is a CYP3A4 modulator, requiring careful review of concomitant medications.
Timing: Prior to administration
Routine Monitoring
Frequency: Post-operatively, as needed
Target: No nausea or vomiting
Action Threshold: Persistent nausea/vomiting may require additional antiemetic therapy.
Frequency: Post-operatively, as needed
Target: Absence or mild, tolerable symptoms
Action Threshold: Severe or persistent adverse effects may require symptomatic treatment or re-evaluation.
Frequency: Closely monitor for 2 weeks after each single dose or 7 days after the last dose of a multi-day regimen.
Target: Individualized therapeutic range
Action Threshold: Significant deviation from target INR may require warfarin dose adjustment.
Symptom Monitoring
- Nausea
- Vomiting
- Headache
- Fatigue
- Dizziness
- Constipation
- Diarrhea
- Dyspepsia
- Hiccups
- Hypotension
- Bradycardia
- Rash
- Pruritus
Special Patient Groups
Pregnancy
Aprepitant is Pregnancy Category B. Animal studies have not shown harm to the fetus, but there are no adequate and well-controlled studies in pregnant women. Use only if clearly needed.
Trimester-Specific Risks:
Lactation
Aprepitant is excreted into breast milk in rats. It is unknown if it is excreted in human milk. The decision to discontinue breastfeeding or discontinue the drug should consider the importance of the drug to the mother and the potential risks to the infant. Lactation risk is L3 (Moderately Safe).
Pediatric Use
Safety and effectiveness of Aprepitant 40mg for PONV have not been established in pediatric patients under 18 years of age. For CINV, specific formulations and dosing are approved for children âĨ6 months.
Geriatric Use
No dose adjustment is necessary based on age. Efficacy and safety profiles are generally similar to younger adults, but elderly patients may be more sensitive to drug effects and potential interactions.
Clinical Information
Clinical Pearls
- Aprepitant 40mg is a single-dose regimen specifically for the prevention of PONV, administered pre-operatively.
- It is a moderate inhibitor of CYP3A4 and a mild inducer of CYP3A4, CYP2C9, and P-glycoprotein, leading to significant drug interactions.
- Crucial to review all concomitant medications, especially warfarin, oral contraceptives, and corticosteroids, due to potential for altered efficacy or toxicity.
- For patients on warfarin, close INR monitoring is essential for up to 2 weeks after aprepitant administration.
- Aprepitant does not treat existing nausea/vomiting; it is for prevention.
Alternative Therapies
- 5-HT3 receptor antagonists (e.g., Ondansetron, Granisetron, Palonosetron)
- Corticosteroids (e.g., Dexamethasone)
- Dopamine receptor antagonists (e.g., Prochlorperazine, Metoclopramide)
- Antihistamines (e.g., Promethazine)
- Anticholinergics (e.g., Scopolamine patch)